PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 126 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $12,573,000 | -11.7% | 1,246,121 | -8.7% | 2.28% | +64.4% |
| Q2 2020 | $14,241,000 | +110.9% | 1,365,376 | +70.7% | 1.38% | +46.0% |
| Q1 2020 | $6,752,000 | +120.9% | 800,000 | +129.0% | 0.95% | +159.7% |
| Q4 2019 | $3,057,000 | -18.7% | 349,400 | 0.0% | 0.36% | -43.2% |
| Q3 2019 | $3,761,000 | -15.3% | 349,400 | 0.0% | 0.64% | +7.2% |
| Q2 2019 | $4,441,000 | -67.2% | 349,400 | 0.0% | 0.60% | -76.0% |
| Q1 2019 | $13,553,000 | +169.2% | 349,400 | +41.2% | 2.50% | +116.2% |
| Q4 2018 | $5,035,000 | – | 247,400 | – | 1.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |